Accolade (NASDAQ:ACCD) posted its quarterly earnings data on Wednesday. The company reported ($0.40) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.42) by $0.02, Fidelity Earnings reports. Accolade updated its FY 2021
After-Hours guidance to EPS and its Q3 2021
After-Hours guidance to EPS.
Accolade stock traded down $4.21 during trading on Thursday, reaching $40.28. The stock had a trading volume of 4,540 shares, compared to its average volume of 314,602. Accolade has a 52-week low of $28.68 and a 52-week high of $44.96. The firm has a 50 day moving average of $35.20.
A number of research firms have commented on ACCD. DA Davidson upped their price target on Accolade from $45.00 to $50.00 and gave the stock a “buy” rating in a research note on Thursday. BofA Securities started coverage on Accolade in a research note on Monday, July 27th. They set a “buy” rating and a $37.00 target price on the stock. SVB Leerink lifted their target price on Accolade from $40.00 to $44.00 and gave the company a “market perform” rating in a research report on Thursday. Morgan Stanley started coverage on shares of Accolade in a research note on Monday, July 27th. They set an “overweight” rating and a $37.00 price target on the stock. Finally, Piper Sandler reissued an “overweight” rating and issued a $55.00 price objective (up previously from $45.00) on shares of Accolade in a research note on Thursday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $44.22.
Accolade, Inc develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. It offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.
Featured Story: What is Liquidity?
Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.